Ipamorelin is a selective Growth Hormone–Releasing Peptide (GHRP) that stimulates the pituitary gland to naturally increase growth hormone (GH) secretion. Known for its clean and well-tolerated profile, Ipamorelin enhances lean muscle development, promotes fat metabolism, and supports overall recovery—making it an ideal peptide for patients seeking improved performance, body composition, and longevity benefits.
Our lyophilized peptides deliver 99%+ purity and are manufactured in the USA with APIs listed on the FDA Green List. We partner exclusively with cGMP and ISO 9001 registered facilities to ensure that every ingredient meets stringent purity and efficacy benchmarks, guaranteeing consistency and efficacy across all production runs. Certificate of Analysis available upon request.
Key Benefits for Your Patients:
- Increased Lean Muscle Growth: Stimulates GH and IGF-1 production to promote muscle development and repair.
- Enhanced Fat Metabolism and Body Composition: Improves lipid utilization, helping reduce body fat while maintaining lean mass.
- Accelerated Recovery and Performance: Speeds up tissue repair and recovery after exercise, injury, or procedures.
- Improved Sleep Quality and Energy: Supports restorative sleep cycles and natural circadian balance, leading to better recovery and vitality.
- Safe and Balanced Hormone Support: Delivers GH enhancement without raising cortisol or prolactin, ensuring a clean and well-tolerated hormonal response.
Ipamorelin provides a gentle yet effective method for promoting natural GH production, making it a preferred peptide for regenerative, performance, and anti-aging medicine. Its clean safety profile, targeted mechanism, and versatility across patient populations make it a cornerstone in metabolic and restorative peptide therapy.
Each vial is provided in lyophilized powder form and must be reconstituted with bacteriostatic water prior to use.
This product is intended for use under the guidance of qualified medical professionals who prioritize precision, quality, and evidence-based peptide therapies in patient care.
